Peter Libby, MD
Advertisement
Articles by Peter Libby, MD
Advertisement
Latest Updated Articles
- Inflammatory markers are useful risk assessment tools
August 1st 2003
Advertisement
Advertisement
Trending on AJMC
1
MFN Drug Agreements Could Raise Prices Worldwide
2
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
3
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
4
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
5